- Home
- TIL vs LNZA Comparison
TIL vs LNZA Comparison
Compare TIL & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- LNZA
- Stock Information
- Founded
- TIL 2018
- LNZA 2005
- Country
- TIL United States
- LNZA United States
- Employees
- TIL N/A
- LNZA N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- LNZA Major Chemicals
- Sector
- TIL Health Care
- LNZA Industrials
- Exchange
- TIL Nasdaq
- LNZA Nasdaq
- Market Cap
- TIL 171.7M
- LNZA 199.8M
- IPO Year
- TIL 2021
- LNZA N/A
- Fundamental
- Price
- TIL $14.48
- LNZA $0.22
- Analyst Decision
- TIL Buy
- LNZA Hold
- Analyst Count
- TIL 5
- LNZA 2
- Target Price
- TIL $114.00
- LNZA $2.00
- AVG Volume (30 Days)
- TIL 178.2K
- LNZA 1.9M
- Earning Date
- TIL 05-13-2025
- LNZA 04-15-2025
- Dividend Yield
- TIL N/A
- LNZA N/A
- EPS Growth
- TIL N/A
- LNZA N/A
- EPS
- TIL N/A
- LNZA N/A
- Revenue
- TIL N/A
- LNZA $49,592,000.00
- Revenue This Year
- TIL N/A
- LNZA $110.74
- Revenue Next Year
- TIL N/A
- LNZA $28.02
- P/E Ratio
- TIL N/A
- LNZA N/A
- Revenue Growth
- TIL N/A
- LNZA N/A
- 52 Week Low
- TIL $9.62
- LNZA $0.14
- 52 Week High
- TIL $92.00
- LNZA $3.26
- Technical
- Relative Strength Index (RSI)
- TIL 46.45
- LNZA 41.32
- Support Level
- TIL $10.80
- LNZA $0.15
- Resistance Level
- TIL $13.52
- LNZA $0.25
- Average True Range (ATR)
- TIL 2.23
- LNZA 0.03
- MACD
- TIL -0.17
- LNZA 0.02
- Stochastic Oscillator
- TIL 27.06
- LNZA 44.05
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.